Sign Up
S 6397 New York Senate · 2019 Regular Session

Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

Summary
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
Bill status passed 3 of 5 stages cleared
Introduction
Jun 2019
Committee Review
Feb 2020
Senate Passage
Feb 2020
Assembly Passage
Governor
Introduced Jun 7, 2019 Last action Feb 4, 2020
Floor votes · Senate Jun 12, 2019

How they voted

53–0
Passed
Total votes 53
Jun 12, 2019
D Democratic36
36 Yea
100% Yea
R Republican17
17 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
14
Key actions
2
Committee
4
Feb 4, 2020
Committee
REFERRED TO INSURANCE
lower
Feb 4, 2020
Upper · Passed
PASSED SENATE
upper
Jan 8, 2020
Committee
REFERRED TO HEALTH
upper
Jun 12, 2019
Committee
REFERRED TO INSURANCE
lower
Jun 12, 2019
Upper · Passed
PASSED SENATE
upper
Jun 7, 2019
Committee
REFERRED TO RULES
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.